The company
UFP Technologies, Inc.
UFPT · Nasdaq
UFPT stood above a rising 150-day average in 31 of the last 52 weekly readings, including each of the last 20 weeks. It is 17.4% above that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−7 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 20 in a row
- Industry in uptrend
- 27% -7 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $27.6M
- Officials’ trades on record
- 4
- Institutions holding
- 259 (+8)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 31 of 52 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
4 disclosed lines: House 0, Senate 0, executive 4; 1 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 29 Jul 2026filed 22 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 30 Apr 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 30 Mar 2026filed 14 May 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 26 Feb 2026filed 14 May 2026 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Marc D. KozinDirector | sold | 3,650at $303.97 | 25 Aug 2026filed 27 Aug 2026 |
| Marc D. KozinDirector | sold | 3,350at $305.07 | 25 Aug 2026filed 27 Aug 2026 |
| Symeria HudsonDirector | sold | 298at $319.11 | 18 Aug 2026filed 19 Aug 2026 |
| Symeria HudsonDirector | sold | 1,926at $324.58 | 14 Aug 2026filed 17 Aug 2026 |
| Cynthia L. FeldmannDirector | sold | 1,000at $324.26 | 13 Aug 2026filed 17 Aug 2026 |
| R. Jeffrey BaillyExecutive Chairman | sold | 5,771at $315.53 | 10 Aug 2026filed 11 Aug 2026 |
| R. Jeffrey BaillyExecutive Chairman | sold | 6,866at $316.58 | 10 Aug 2026filed 11 Aug 2026 |
| R. Jeffrey BaillyExecutive Chairman | sold | 374at $317.27 | 10 Aug 2026filed 11 Aug 2026 |
| R. Jeffrey BaillyExecutive Chairman | sold | 542at $315.06 | 7 Aug 2026filed 10 Aug 2026 |
| R. Jeffrey BaillyExecutive Chairman | sold | 4,471at $318.21 | 7 Aug 2026filed 10 Aug 2026 |
| Jason HoltVice President | sold | 1,100at $317.00 | 6 Aug 2026filed 7 Aug 2026 |
| R. Jeffrey BaillyExecutive Chairman | sold | 7,877at $318.12 | 6 Aug 2026filed 10 Aug 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 1,141,410$302.6M | +44,227+4.0% |
| CONGRESS ASSET MANAGEMENT COadded · filed 7 Jul 2026 | 687,439$182.3M | +164,001+31.3% |
| WASATCH ADVISORS LPreduced · filed 10 Jul 2026 | 683,262$181.2M | -94,051−12.1% |
| NEUBERGER BERMAN GROUP LLCadded · filed 13 Aug 2026 | 537,038$142.4M | +236,445+78.7% |
| Boston Trust Walden Corpadded · filed 24 Jul 2026 | 336,278$89.2M | +19,206+6.1% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 329,623$87.4M | +2,898+0.9% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 312,811$82.9M | +9,498+3.1% |
| AMERICAN CENTURY COMPANIES INCadded · filed 12 Aug 2026 | 279,976$74.2M | +154,116+122.5% |
| UBS Group AGadded · filed 13 Aug 2026 | 254,740$67.5M | +81,000+46.6% |
| MASSACHUSETTS FINANCIAL SERVICES COreduced · filed 3 Aug 2026 | 223,474$59.2M | -3,829−1.7% |
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.